Notably, PGRN showed therapeutic effects in various TNF-mediated inflammatory arthritis models, including collagen-induced arthritis and spontaneous arthritis in the TNF-transgenic model (Liu, 2011; Liu and Bosch, 2012; Tang et al., 2011; Wei et al., 2014a). This evidence concerns the gene GRN and arthritic joint disease.